Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®
NCT04667039
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
408
Enrollment
INDUSTRY
Sponsor class
Conditions
Age Related Macular Degeneration (ARMD)
Interventions
BIOLOGICAL:
GNR-067
BIOLOGICAL:
Lucentis®
Sponsor
AO GENERIUM